Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12614001018606
ACTRN12614001018606
Completed
未知

A preliminary examination of the Concurrent Treatment of PTSD and Substance Use Disorders using Prolonged Exposure - Adolescent (COPE-A) intervention: Designed to reduce traumatic stress symptoms and substance use among adolescents aged 12-17yrs

Mental Health and Drug and Alcohol Office (MHDAO)0 sites10 target enrollmentSeptember 22, 2014
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Mental Health and Drug and Alcohol Office (MHDAO)
Enrollment
10
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 22, 2014
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Mental Health and Drug and Alcohol Office (MHDAO)

Eligibility Criteria

Inclusion Criteria

  • •(i) aged between 12\-17 years,
  • •(ii) substance use in the past month,
  • •(iii) lifetime exposure to at least one traumatic event,
  • •(iv) partial or full diagnosis of current PTSD.

Exclusion Criteria

  • •(i) recent history of suicide or self\-harm,
  • •(ii) chronic psychosis,
  • •(iii) organic or traumatic brain injury, or
  • •(iv) ongoing trauma\-related threat or ongoing unsupervised contact with the alleged perpetrator.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Effectiveness of Unified Protocol in Anxiety Disorders
CTRI/2021/01/030803niversity Grants Commission
Completed
Not Applicable
A Preliminary Evaluation of an Acceptance and Commitment Therapy Based Program for Adult Congenital Heart Disease Patients.resiliencedepressionanxietystressquality of lifeAdult congenital heart diseaseMental Health - DepressionMental Health - AnxietyCardiovascular - Other cardiovascular diseases
ACTRN12614000425695The Prince Charles Hospital30
Completed
Phase 2
CEREBRAL PALSY IN CHILDREN.
CTRI/2015/07/006038Institute for Post Graduate Teaching and Research in Ayurveda jamnagar20
Active, not recruiting
Phase 1
The CONFRONT Phase I – II Trial: ACtivatiON oF immune RespONse in paTients with R-M Head and Neck Cancer. Multimodality immunotherapy with Avelumab, short course radiotherapy and Cyclophosphamide in Head and Neck cancer.R-M Head and Neck CancerMedDRA version: 20.0Level: PTClassification code 10034813Term: Pharyngeal cancer recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10055104Term: Pharyngeal cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2017-000353-39-ITG.O.N.O. - GRUPPO ONCOLOGICO DEL NORD OVEST71
Completed
Not Applicable
A PHASE II PROSPECTIVE TRIAL CORRELATING THE PROGRESSION FREE SURVIVAL CYP2D6 WITH ACTIVITY IN PATIENTS WITH METASTATIC BREAST CANCER TREATED WITH SINGLE AGENT TAMOXIFE-C61 Malignant neoplasm of prostateMalignant neoplasm of prostateC61
PER-114-10EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG), GRUPO DE ESTUDIOS CLINICOS ONCOLOGICO DEL PERU GECOPERU,37